Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data
Clicks: 292
ID: 119097
1998
A meta-analysis of 8 randomized trials (1792 patients, 2947 patient-years of follow-up) showed that acyclovir (> or = 3200 mg/day) offered a significant survival benefit (P = .006 by log-rank test) in human immunodeficiency virus (HIV) infection. The treatment effect did not vary significantly in …
| Reference Key |
jp1998theclinical
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Ioannidis JP;Collier AC;Cooper DA;Corey L;Fiddian AP;Gazzard BG;Griffiths PD;Contopoulos-Ioannidis DG;Lau J;Pavia AT;Saag MS;Spruance SL;Youle MS;; |
| Journal | The Journal of infectious diseases |
| Year | 1998 |
| DOI | DOI not found |
| URL | |
| Keywords |
meta-analysis
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
u.s. gov't
adult
female
male
P.H.S.
follow-up studies
dose-response relationship
drug
anti-hiv agents / therapeutic use*
hiv infections / drug therapy*
acyclovir / therapeutic use*
randomized controlled trials as topic*
pmid:9697714
doi:10.1086/515621
j p ioannidis
a c collier
m s youle
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.